These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Nesiritide in heart failure: commercial success or therapeutic advance?]. Stampfli T; Perrier A Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047 [TBL] [Abstract][Full Text] [Related]
26. The role of intravenous vasodilators in acute heart failure management. Piper S; McDonagh T Eur J Heart Fail; 2014 Aug; 16(8):827-34. PubMed ID: 25100108 [TBL] [Abstract][Full Text] [Related]
27. [Vasodilator therapy in heart failure (author's transl)]. Kimata S Kokyu To Junkan; 1978 Sep; 26(9):863-72. PubMed ID: 100840 [No Abstract] [Full Text] [Related]
28. The role of venodilators in the perioperative management of heart failure. Valchanov KP; Arrowsmith JE Eur J Anaesthesiol; 2012 Mar; 29(3):121-8. PubMed ID: 22273830 [TBL] [Abstract][Full Text] [Related]
29. Nesiritide - not verified. Topol EJ N Engl J Med; 2005 Jul; 353(2):113-6. PubMed ID: 16014879 [No Abstract] [Full Text] [Related]
30. Optimizing outcomes in the patient with acute decompensated heart failure. Mehra MR Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617 [TBL] [Abstract][Full Text] [Related]
31. Nesiritide for the treatment of congestive heart failure. Iyengar S; Feldman DS; Trupp R; Abraham WT Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572 [TBL] [Abstract][Full Text] [Related]
33. Management of acute decompensated heart failure: treatment, controversy, and future directions. Munger MA Pharmacotherapy; 2006 Aug; 26(8 Pt 2):131S-138S. PubMed ID: 16863479 [TBL] [Abstract][Full Text] [Related]
34. Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics. Moffett BS; Jefferies JL; Price JF; Clunie S; Denfield S; Dreyer WJ; Towbin JA Pharmacotherapy; 2006 Feb; 26(2):277-80. PubMed ID: 16466333 [TBL] [Abstract][Full Text] [Related]
35. [Physiopathologic and pharmacodynamic rationale for the use of nitrate compounds in cardiac decompensation]. Geraci E G Ital Cardiol; 1996 Sep; 26(9):1073-7. PubMed ID: 9036048 [No Abstract] [Full Text] [Related]
37. [Peripheral vasodilators in the treatment of heart failure]. Serbin VI; Gasanova AS Pediatriia; 1982 Jan; (1):67-70. PubMed ID: 7038611 [No Abstract] [Full Text] [Related]
38. [Vasodilator therapy of heart failure]. Mathey D Dtsch Med Wochenschr; 1979 Apr; 104(16):563-4. PubMed ID: 108068 [No Abstract] [Full Text] [Related]
39. [The role of vasodilators in the treatment of congestive heart failure and myocardial ischaemia (author's transl)]. Tarnow J Anaesthesist; 1981 Jun; 30(6):269-79. PubMed ID: 6791517 [TBL] [Abstract][Full Text] [Related]
40. Milrinone: a positive inotropic vasodilator. Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]